发明名称 VECTOR
摘要 <p>PROBLEM TO BE SOLVED: To obtain a vector that is useful for treatment of genepathy that is independent from the integration site, induces the expression of the gene in the copy-number-dependent mode by including a dominant activator sequence bearing a specific CD2-DNase I hypersensitive site. SOLUTION: This is a vector for integrating a gene into the genetic material in the host cells of a mammalian so that the gene may be expressed by the host cells and comprises the promoter and the gene. In this case, the vector is restricted by the host cell type, when the gene is expressed, independent from the integration site and can induce the copy count-independent expression. The vector includes the CD2 DNase I hyper-sensitive site and bears the dominant activator sequence in the fragment of 5.5 kb BamHI-XbaI on the 3' side of the CD 2 gene.</p>
申请公布号 JP2000245462(A) 申请公布日期 2000.09.12
申请号 JP19990321813 申请日期 1999.11.11
申请人 MEDICAL RES COUNCIL:THE 发明人 GROSVELD FRANKLIN G
分类号 C12N15/09;A01K67/027;A61K31/711;A61K35/76;A61K38/16;A61K48/00;A61P7/06;C07K14/705;C07K14/805;C12N5/00;C12N5/10;C12N15/85;C12N15/90;C12P21/00;C12R1/91;(IPC1-7):C12N15/09 主分类号 C12N15/09
代理机构 代理人
主权项
地址